Junctions gone bad: Claudins and loss of the barrier in cancer

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1816, Issue 1, 2011, Pages 73-79

  Turksen, Kursad ^a,b,c   Troy, Tammy Claire ^a  

^a OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Cancer; Claudin; Epithelia; Permeability barrier; Tight junction

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BUTYRIC ACID; CLAUDIN; CLAUDIN 1; CLAUDIN 11; CLAUDIN 16; CLAUDIN 18; CLAUDIN 2; CLAUDIN 3; CLAUDIN 4; CLAUDIN 5; CLAUDIN 6; CLAUDIN 7; CLAUDIN 8; HISTONE DEACETYLASE INHIBITOR; TRICHOSTATIN A;

BLADDER CARCINOMA; BREAST CANCER; CARCINOGENESIS; CELL MEMBRANE PERMEABILITY; COLORECTAL CANCER; DRUG EFFECT; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; HUMAN; INTESTINE CARCINOMA; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; NASOPHARYNX CARCINOMA; NEOPLASM; NONHUMAN; OVARY CANCER; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SKIN PAPILLOMA; STOMACH CANCER; TIGHT JUNCTION; TONGUE CARCINOMA;

EID: 79955754617     PISSN: 0304419X     EISSN: 0304419X     Source Type: Journal    
DOI: 10.1016/j.bbcan.2011.04.001     Document Type: Review

References (151)

1. Farquhar M.G., Palade G.E. Junctional complexes in various epithelia. J. Cell Biol. 1963, 17:375-412.
2. Giepmans B.N., van Ijzendoorn S.C. Epithelial cell-cell junctions and plasma membrane domains. Biochim. Biophys. Acta 2009, 1788:820-831.
3. Cereijido M., Contreras R.G., Shoshani L., Flores-Benitez D., Larre I. Tight junction and polarity interaction in the transporting epithelial phenotype. Biochim. Biophys. Acta 2008, 1778:770-793.
4. Friend D.S., Gilula N.B. Variations in tight and gap junctions in mammalian tissues. J. Cell Biol. 1972, 53:758-776.
5. Marchiando A.M., Graham W.V., Turner J.R. Epithelial barriers in homeostasis and disease. Annu. Rev. Pathol. 2010, 5:119-144.
6. Martin T.A., Jiang W.G. Tight junctions and their role in cancer metastasis. Histol. Histopathol. 2001, 16:1183-1195.
7. Martin T.A., Jiang W.G. Loss of tight junction barrier function and its role in cancer metastasis. Biochim. Biophys. Acta 2009, 1788:872-891.
8. Madara J.L. Regulation, of the movement of solutes across tight junctions. Annu. Rev. Physiol. 1998, 60:143-159.
9. Mullin J.M., Agostino N., Rendon-Huerta E., Thornton J.J. Keynote review: epithelial and endothelial barriers in human disease. Drug Discov. Today 2005, 10:395-408.
10. Landau D. Epithelial paracellular proteins in health and disease. Curr. Opin. Nephrol. Hypertens. 2006, 15:425-429.
11. Forster C. Tight junctions and the modulation of barrier function in disease. Histochem. Cell Biol. 2008, 130:55-70.
12. Furuse M., Fujita K., Hiiragi T., Fujimoto K., Tsukita S. Claudin-1 and-2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J. Cell Biol. 1998, 141:1539-1550.
13. Brandner J.M., Kief S., Grund C., Rendl M., Houdek P., Kuhn C., Tschachler E., Franke W.W., Moll I. Organization and formation of the tight junction system in human epidermis and cultured keratinocytes. Eur. J. Cell Biol. 2002, 81:253-263.
14. Schneeberger E.E., Lynch R.D. Tight junctions. Their structure, composition, and function. Circ. Res. 1984, 55:723-733.
15. Staehelin L.A., Mukherjee T.M., Williams A.W. Fine structure of frozen-etched tight junctions. Naturwissenschaften 1969, 56:142.
16. Staehelin L.A. Further, observations on the fine structure of freeze-cleaved tight junctions. J. Cell Sci. 1973, 13:763-786.
17. Staehelin L.A., Mukherjee T.M., Williams A.W. Freeze-etch appearance of the tight junctions in the epithelium of small and large intestine of mice. Protoplasma 1969, 67:165-184.
18. Gumbiner B. Structure, biochemistry, and assembly of epithelial tight junctions. Am. J. Physiol. 1987, 253:C749-C758.
19. Madara J.L. Tight junction dynamics: is paracellular transport regulated?. Cell 1988, 53:497-498.
20. Watson A.J., Barcroft L.C. Regulation of blastocyst formation. Front. Biosci. 2001, 6:D708-D730.
21. Sheth B., Fontaine J.J., Ponza E., McCallum A., Page A., Citi S., Louvard D., Zahraoui A., Fleming T.P. Differentiation of the epithelial apical junctional complex during mouse preimplantation development: a role for rab13 in the early maturation of the tight junction. Mech. Dev. 2000, 97:93-104.
22. Eckert J.J., Fleming T.P. Tight junction biogenesis during early development. Biochim. Biophys. Acta 2008, 1778:717-728.
23. Turksen K., Troy T.C. Permeability barrier dysfunction in transgenic mice overexpressing claudin 6. Development 2002, 129:1775-1784.
24. Turksen K., Troy T.C. Overexpression of the calcium sensing receptor accelerates epidermal differentiation and permeability barrier formation in vivo. Mech. Dev. 2003, 120:733-744.
25. Schneeberger E.E., Walters D.V., Olver R.E. Development of intercellular junctions in the pulmonary epithelium of the foetal lamb. J. Cell Sci. 1978, 32:307-324.
26. Whittembury G., Rawlins F.A. Evidence of a paracellular pathway for ion flow in the kidney proximal tubule. Electromicroscopic demonstration of lanthanum precipitate in the tight junction. Pflugers Arch. 1971, 330:302-309.
27. Machen T.E., Erlij D., Wooding F.B. Permeable junctional complexes. The movement of lanthanum across rabbit gallbladder and intestine. J. Cell Biol. 1972, 54:302-312.
28. Nadol J.B., Mulroy M.J., Goodenough D.A., Weiss T.F. Tight and gap junctions in a vertebrate inner ear. Am. J. Anat. 1976, 147:281-301.
29. Hardison W.G., Dalle-Molle E., Gosink E., Lowe P.J., Steinbach J.H., Yamaguchi Y. Function of rat hepatocyte tight junctions: studies with bile acid infusions. Am. J. Physiol. 1991, 260:G167-G174.
30. Cereijido M., Robbins E.S., Dolan W.J., Rotunno C.A., Sabatini D.D. Polarized monolayers formed by epithelial cells on a permeable and translucent support. J. Cell Biol. 1978, 77:853-880.
31. Moreno J.H., Diamond J.M. Cation permeation mechanisms and cation selectivity in "tight junctions" of gallbladder epithelium. Membranes 1975, 3:383-497.
32. Madara J.L. Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: physiological rearrangement of tight junctions. J. Membr. Biol. 1990, 116:177-184.
33. Lowe P.J., Miyai K., Steinbach J.H., Hardison W.G. Hormonal regulation of hepatocyte tight junctional permeability. Am. J. Physiol. 1988, 255:G454-G461.
34. Amsterdam A., Ohad I., Schramm M. Dynamic changes in the ultrastructure of the acinar cell of the rat parotid gland during the secretory cycle. J. Cell Biol. 1969, 41:753-773.
35. Furuse M., Hirase T., Itoh M., Nagafuchi A., Yonemura S., Tsukita S. Occludin: a novel integral membrane protein localizing at tight junctions. J. Cell Biol. 1993, 123:1777-1788.
36. Saitou M., Furuse M., Sasaki H., Schulzke J.D., Fromm M., Takano H., Noda T., Tsukita S. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol. Biol. Cell 2000, 11:4131-4142.
37. Saitou M., Fujimoto K., Doi Y., Itoh M., Fujimoto T., Furuse M., Takano H., Noda T., Tsukita S. Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J. Cell Biol. 1998, 141:397-408.
38. Turksen K. Wasted salts and wasted bodies: new insight into the role of claudin 7 in the kidney. Am. J. Physiol. Renal Physiol. 2010, 298:F22-F23.
39. Tatum R., Zhang Y., Salleng K., Lu Z., Lin J.J., Lu Q., Jeansonne B.G., Ding L., Chen Y.H. Renal salt wasting and chronic dehydration in claudin-7-deficient mice. Am. J. Physiol. Renal Physiol. 2010, 298:F24-F34.
40. Enikanolaiye A., Lariviere N., Troy T.C., Arabzadeh A., Atasoy E., Turksen K. Involucrin-claudin-6 tail deletion mutant (CDelta206) transgenic mice: a model of delayed epidermal permeability barrier formation and repair. Dis. Model. Mech. 2010, 3:167-180.
41. Daugherty B.L., Mateescu M., Patel A.S., Wade K., Kimura S., Gonzales L.W., Guttentag S., Ballard P.L., Koval M. Developmental regulation of claudin localization by fetal alveolar epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287:L1266-L1273.
42. Gupta I.R., Ryan A.K. Claudins: unlocking the code to tight junction function during embryogenesis and in disease. Clin. Genet. 2010, 77:314-325.
43. Angelow S., Ahlstrom R., Yu A.S. Biology of Claudins. Am. J. Physiol. Renal Physiol. 2008, 295(4):F867-F876.
44. Van Itallie C.M., Anderson J.M. Claudins and epithelial paracellular transport. Annu. Rev. Physiol. 2006, 68:403-429.
45. Angelow S., Yu A.S. Claudins and paracellular transport: an update. Curr. Opin. Nephrol. Hypertens. 2007, 16:459-464.
46. Krause G., Winkler L., Mueller S.L., Haseloff R.F., Piontek J., Blasig I.E. Structure and function of claudins. Biochim. Biophys. Acta 2008, 1778:631-645.
47. Colegio O.R., Van Itallie C., Rahner C., Anderson J.M. Claudin extracellular domains determine paracellular charge selectivity and resistance but not tight junction fibril architecture. Am. J. Physiol. Cell Physiol. 2003, 284:C1346-C1354.
48. Colegio O.R., Van Itallie C.M., McCrea H.J., Rahner C., Anderson J.M. Claudins create charge-selective channels in the paracellular pathway between epithelial cells. Am. J. Physiol. Cell Physiol. 2002, 283:C142-C147.
49. Piontek J., Winkler L., Wolburg H., Muller S.L., Zuleger N., Piehl C., Wiesner B., Krause G., Blasig I.E. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J. 2008, 22:146-158.
50. Turksen K., Troy T.C. Barriers built on claudins. J. Cell Sci. 2004, 117:2435-2447.
51. Furuse M., Moriwaki K. The role of claudin-based tight junctions in morphogenesis. Ann. N.Y. Acad. Sci. 2009, 1165:58-61.
52. Arabzadeh A., Troy T.C., Turksen K. Changes in the distribution pattern of Claudin tight junction proteins during the progression of mouse skin tumorigenesis. BMC Cancer 2007, 7:196.
53. Palekar M.S., Sirsat S.M. Lanthanum staining of cell surface and junctional complexes in normal and malignant human oral mucosa. J. Oral Pathol. 1975, 4:231-243.
54. Johnson R.G., Sheridan J.D. Junctions between cancer cells in culture: ultrastructure and permeability. Science 1971, 174:717-719.
55. Montgomery E., Mamelak A.J., Gibson M., Maitra A., Sheikh S., Amr S.S., Yang S., Brock M., Forastiere A., Zhang S., Murphy K.M., Berg K.D. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions. Appl. Immunohistochem. Mol. Morphol. 2006, 14:24-30.
56. Cunningham S.C., Kamangar F., Kim M.P., Hammoud S., Haque R., Iacobuzio-Donahue C.A., Maitra A., Ashfaq R., Hustinx S., Heitmiller R.E., Choti M.A., Lillemoe K.D., Cameron J.L., Yeo C.J., Schulick R.D., Montgomery E. Claudin-4, mitogen-activated protein kinase kinase 4, and stratifin are markers of gastric adenocarcinoma precursor lesions. Cancer Epidemiol. Biomarkers Prev. 2006, 15:281-287.
57. Lee J.W., Lee S.J., Seo J., Song S.Y., Ahn G., Park C.S., Lee J.H., Kim B.G., Bae D.S. Increased expressions of claudin-1 and claudin-7 during the progression of cervical neoplasia. Gynecol. Oncol. 2005, 97:53-59.
58. Erin N., Wang N., Xin P., Bui V., Weisz J., Barkan G.A., Zhao W., Shearer D., Clawson G.A. Altered gene expression in breast cancer liver metastases. Int. J. Cancer 2009, 124:1503-1516.
59. Sauer T., Pedersen M.K., Ebeltoft K., Naess O. Reduced expression of Claudin-7 in fine needle aspirates from breast carcinomas correlate with grading and metastatic disease. Cytopathology 2005, 16:193-198.
60. Al Moustafa A.E., Alaoui-Jamali M.A., Batist G., Hernandez-Perez M., Serruya C., Alpert L., Black M.J., Sladek R., Foulkes W.D. Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002, 21:2634-2640.
61. Martin T.A., Harrison G.M., Watkins G., Jiang W.G. Claudin-16 reduces the aggressive behavior of human breast cancer cells. J. Cell. Biochem. 2008, 105:41-52.
62. Tassi R.A., Bignotti E., Falchetti M., Ravanini M., Calza S., Ravaggi A., Bandiera E., Facchetti F., Pecorelli S., Santin A.D. Claudin-7 expression in human epithelial ovarian cancer. Int. J. Gynecol. Cancer 2008, 18:1262-1271.
63. Hough C.D., Sherman-Baust C.A., Pizer E.S., Montz F.J., Im D.D., Rosenshein N.B., Cho K.R., Riggins G.J., Morin P.J. Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res. 2000, 60:6281-6287.
64. Rangel L.B., Sherman-Baust C.A., Wernyj R.P., Schwartz D.R., Cho K.R., Morin P.J. Characterization of novel human ovarian cancer-specific transcripts (HOSTs) identified by serial analysis of gene expression. Oncogene 2003, 22:7225-7232.
65. Sanada Y., Oue N., Mitani Y., Yoshida K., Nakayama H., Yasui W. Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J. Pathol. 2006, 208:633-642.
66. Hewitt K.J., Agarwal R., Morin P.J. The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 2006, 6:186.
67. Bignotti E., Tassi R.A., Calza S., Ravaggi A., Romani C., Rossi E., Falchetti M., Odicino F.E., Pecorelli S., Santin A.D. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. Gynecol. Oncol. 2006, 103:405-416.
68. Santin A.D., Zhan F., Cane S., Bellone S., Palmieri M., Thomas M., Burnett A., Roman J.J., Cannon M.J., Shaughnessy J., Pecorelli S. Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy. Br. J. Cancer 2005, 92:1561-1573.
69. Heinzelmann-Schwarz V.A., Gardiner-Garden M., Henshall S.M., Scurry J., Scolyer R.A., Davies M.J., Heinzelmann M., Kalish L.H., Bali A., Kench J.G., Edwards L.S., Vanden Bergh P.M., Hacker N.F., Sutherland R.L., O'Brien P.M. Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer. Clin. Cancer Res. 2004, 10:4427-4436.
70. Chen J.S., Chen K.T., Fan C.W., Han C.L., Chen Y.J., Yu J.S., Chang Y.S., Chien C.W., Wu C.P., Hung R.P., Chan E.C. Comparison of membrane fraction proteomic profiles of normal and cancerous human colorectal tissues with gel-assisted digestion and iTRAQ labeling mass spectrometry. FEBS J. 2010, 277(14):3028-3038.
71. Resnick M.B., Konkin T., Routhier J., Sabo E., Pricolo V.E. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod. Pathol. 2005, 18:511-518.
72. Morohashi S., Kusumi T., Sato F., Odagiri H., Chiba H., Yoshihara S., Hakamada K., Sasaki M., Kijima H. Decreased expression of claudin-1 correlates with recurrence status in breast cancer. Int. J. Mol. Med. 2007, 20:139-143.
73. Tokes A.M., Kulka J., Paku S., Szik A., Paska C., Novak P.K., Szilak L., Kiss A., Bogi K., Schaff Z. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res. 2005, 7:R296-R305.
74. Vare P., Loikkanen I., Hirvikoski P., Vaarala M.H., Soini Y. Low claudin expression is associated with high Gleason grade in prostate adenocarcinoma. Oncol. Rep. 2008, 19:25-31.
75. Hsueh C., Chang Y.S., Tseng N.M., Liao C.T., Hsueh S., Chang J.H., Wu I.C., Chang K.P. Expression pattern and prognostic significance of claudins 1, 4, and 7 in nasopharyngeal carcinoma. Hum. Pathol. 2010, 41:944-950.
76. Quan C., Lu S.J. Identification of genes preferentially expressed in mammary epithelial cells of copenhagen rat using subtractive hybridization and microarrays. Carcinogenesis 2003, 24(10):1593-1599.
77. Wu Q., Liu Y., Ren Y., Xu X., Yu L., Li Y., Quan C. Tight junction protein, claudin-6, downregulates the malignant phenotype of breast carcinoma. Eur. J. Cancer Prev. 2010, 19:186-194.
78. Osanai M., Murata M., Chiba H., Kojima T., Sawada N. Epigenetic silencing of claudin-6 promotes anchorage-independent growth of breast carcinoma cells. Cancer Sci. 2007, 98:1557-1562.
79. Myal Y., Leygue E., Blanchard A.A. Claudin 1 in breast tumorigenesis: revelation of a possible novel "claudin high" subset of breast cancers. J. Biomed. Biotechnol. 2010, 2010:956897.
80. Kramer F., White K., Kubbies M., Swisshelm K., Weber B.H. Genomic organization of claudin-1 and its assessment in hereditary and sporadic breast cancer. Hum. Genet. 2000, 107:249-256.
81. Gopalakrishnan S., Van Emburgh B.O., Robertson K.D. DNA methylation in development and human disease. Mutat. Res. 2008, 647:30-38.
82. Boireau S., Buchert M., Samuel M.S., Pannequin J., Ryan J.L., Choquet A., Chapuis H., Rebillard X., Avances C., Ernst M., Joubert D., Mottet N., Hollande F. DNA-methylation-dependent alterations of claudin-4 expression in human bladder carcinoma. Carcinogenesis 2007, 28:246-258.
83. Kwon M.J., Kim S.S., Choi Y.L., Jung H.S., Balch C., Kim S.H., Song Y.S., Marquez V.E., Nephew K.P., Shin Y.K. Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications. Carcinogenesis 2010, 31:974-983.
84. Krishnan M., Singh A.B., Smith J.J., Sharma A., Chen X., Eschrich S., Yeatman T.J., Beauchamp R.D., Dhawan P. HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability. Oncogene 2010, 29(2):305-312.
85. Oka D., Yamashita S., Tomioka T., Nakanishi Y., Kato H., Kaminishi M., Ushijima T. The presence of aberrant DNA methylation in noncancerous esophageal mucosae in association with smoking history: a target for risk diagnosis and prevention of esophageal cancers. Cancer 2009, 115:3412-3426.
86. Kalluri R., Weinberg R.A. The basics of epithelial-mesenchymal transition. J. Clin. Invest. 2009, 119:1420-1428.
87. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139:871-890.
88. Martinez-Estrada O.M., Culleres A., Soriano F.X., Peinado H., Bolos V., Martinez F.O., Reina M., Cano A., Fabre M., Vilaro S. The transcription factors Slug and Snail act as repressors of Claudin-1 expression in epithelial cells. Biochem. J. 2006, 394:449-457.
89. Papageorgis P., Lambert A.W., Ozturk S., Gao F., Pan H., Manne U., Alekseyev Y.O., Thiagalingam A., Abdolmaleky H.M., Lenburg M., Thiagalingam S. Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Res. 2010, 70:968-978.
90. Miyamori H., Takino T., Kobayashi Y., Tokai H., Itoh Y., Seiki M., Sato H. Claudin promotes activation of pro-matrix metalloproteinase-2 mediated by membrane-type matrix metalloproteinases. J. Biol. Chem. 2001, 276:28204-28211.
91. Ip Y.C., Cheung S.T., Lee Y.T., Ho J.C., Fan S.T. Inhibition of hepatocellular carcinoma invasion by suppression of claudin-10 in HLE cells. Mol. Cancer Ther. 2007, 6:2858-2867.
92. Michl P., Barth C., Buchholz M., Lerch M.M., Rolke M., Holzmann K.H., Menke A., Fensterer H., Giehl K., Lohr M., Leder G., Iwamura T., Adler G., Gress T.M. Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res. 2003, 63:6265-6271.
93. Morita K., Furuse M., Yoshida Y., Itoh M., Sasaki H., Tsukita S., Miyachi Y. Molecular architecture of tight junctions of periderm differs from that of the maculae occludentes of epidermis. J. Invest. Dermatol. 2002, 118:1073-1079.
94. Furuse M., Hata M., Furuse K., Yoshida Y., Haratake A., Sugitani Y., Noda T., Kubo A., Tsukita S. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J. Cell Biol. 2002, 156:1099-1111.
95. Tebbe B., Mankertz J., Schwarz C., Amasheh S., Fromm M., Assaf C., Schultz-Ehrenburg U., Sanchez Ruderish H., Schulzke J.D., Orfanos C.E. Tight junction proteins: a novel class of integral membrane proteins. Expression in human epidermis and in HaCaT keratinocytes. Arch. Dermatol. Res. 2002, 294:14-18.
96. Ban Y., Dota A., Cooper L.J., Fullwood N.J., Nakamura T., Tsuzuki M., Mochida C., Kinoshita S. Tight junction-related protein expression and distribution in human corneal epithelium. Exp. Eye Res. 2003, 76:663-669.
97. Kominsky S.L., Argani P., Korz D., Evron E., Raman V., Garrett E., Rein A., Sauter G., Kallioniemi O.P., Sukumar S. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 2003, 22:2021-2033.
98. Nichols L.S., Ashfaq R., Iacobuzio-Donahue C.A. Claudin 4 protein expression in primary and metastatic pancreatic cancer: support for use as a therapeutic target. Am. J. Clin. Pathol. 2004, 121:226-230.
99. Rahner C., Mitic L.L., Anderson J.M. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 2001, 120:411-422.
100. Rangel L.B., Agarwal R., D'Souza T., Pizer E.S., Alo P.L., Lancaster W.D., Gregoire L., Schwartz D.R., Cho K.R., Morin P.J. Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas. Clin. Cancer Res. 2003, 9:2567-2575.
101. Zhu Y., Maric J., Nilsson M., Brannstrom M., Janson P.O., Sundfeldt K. Formation and barrier function of tight junctions in human ovarian surface epithelium. Biol. Reprod. 2004, 71:53-59.
102. Li W.Y., Huey C.L., Yu A.S. Expression of claudin-7 and -8 along the mouse nephron. Am. J. Physiol. Renal Physiol. 2004, 286:F1063-F1071.
103. Muller D., Kausalya P.J., Claverie-Martin F., Meij I.C., Eggert P., Garcia-Nieto V., Hunziker W. A novel claudin 16 mutation associated with childhood hypercalciuria abolishes binding to ZO-1 and results in lysosomal mistargeting. Am. J. Hum. Genet. 2003, 73:1293-1301.
104. Kiuchi-Saishin Y., Gotoh S., Furuse M., Takasuga A., Tano Y., Tsukita S. Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments. J. Am. Soc. Nephrol. 2002, 13:875-886.
105. Reyes J.L., Lamas M., Martin D., del Carmen Namorado M., Islas S., Luna J., Tauc M., Gonzalez-Mariscal L. The renal segmental distribution of claudins changes with development. Kidney Int. 2002, 62:476-487.
106. Yu A.S., Enck A.H., Lencer W.I., Schneeberger E.E. Claudin-8 expression in Madin-Darby canine kidney cells augments the paracellular barrier to cation permeation. J. Biol. Chem. 2003, 278:17350-17359.
107. Coyne C.B., Gambling T.M., Boucher R.C., Carson J.L., Johnson L.G. Role of claudin interactions in airway tight junctional permeability. Am. J. Physiol. Lung Cell. Mol. Physiol. 2003, 285:L1166-L1178.
108. Niimi T., Nagashima K., Ward J.M., Minoo P., Zimonjic D.B., Popescu N.C., Kimura S. Claudin-18, a novel downstream target gene for the T/EBP/NKX2.1 homeodomain transcription factor, encodes lung- and stomach-specific isoforms through alternative splicing. Mol. Cell. Biol. 2001, 21:7380-7390.
109. Wang F., Daugherty B., Keise L.L., Wei Z., Foley J.P., Savani R.C., Koval M. Heterogeneity of claudin expression by alveolar epithelial cells. Am. J. Respir. Cell Mol. Biol. 2003, 29(1):62-70.
110. Kojima T., Yamamoto T., Murata M., Lan M., Takano K., Go M., Ichimiya S., Chiba H., Sawada N. Role of the p38 MAP-kinase signaling pathway for Cx32 and claudin-1 in the rat liver. Cell Commun. Adhes. 2003, 10:437-443.
111. Mazzon E., Cuzzocrea S. Role of iNOS in hepatocyte tight junction alteration in mouse model of experimental colitis. Cell Mol Biol (Noisy le grand) 2003, 49:45-57.
112. Tamagawa H., Takahashi I., Furuse M., Yoshitake-Kitano Y., Tsukita S., Ito T., Matsuda H., Kiyono H. Characteristics of claudin expression in follicle-associated epithelium of Peyer's patches: preferential localization of claudin-4 at the apex of the dome region. Lab. Invest. 2003, 83:1045-1053.
113. Katoh M. CLDN23 gene, frequently down-regulated in intestinal-type gastric cancer, is a novel member of CLAUDIN gene family. Int. J. Mol. Med. 2003, 11:683-689.
114. Troy T.C., Arabzadeh A., Yerlikaya S., Turksen K. Claudin immunolocalization in neonatal mouse epithelial tissues. Cell Tissue Res. 2007, 330:381-388.
115. Orchard M.D., Murphy C.R. Alterations in tight junction molecules of uterine epithelial cells during early pregnancy in the rat. Acta Histochem. 2002, 104:149-155.
116. Kulka J., Szasz A.M., Nemeth Z., Madaras L., Schaff Z., Molnar I.A., Tokes A.M. Expression of tight junction protein claudin-4 in basal-like breast carcinomas. Pathol. Oncol. Res. 2009, 15:59-64.
117. Blanchard A.A., Skliris G.P., Watson P.H., Murphy L.C., Penner C., Tomes L., Young T.L., Leygue E., Myal Y. Claudins 1, 3, and 4 protein expression in ER negative breast cancer correlates with markers of the basal phenotype. Virchows Arch. 2009, 454:647-656.
118. Lanigan F., McKiernan E., Brennan D.J., Hegarty S., Millikan R.C., McBryan J., Jirstrom K., Landberg G., Martin F., Duffy M.J., Gallagher W.M. Increased claudin-4 expression is associated with poor prognosis and high tumour grade in breast cancer. Int. J. Cancer 2009, 124:2088-2097.
119. Kim T.H., Huh J.H., Lee S., Kang H., Kim G.I., An H.J. Down-regulation of claudin-2 in breast carcinomas is associated with advanced disease. Histopathology 2008, 53:48-55.
120. Nakayama F., Semba S., Usami Y., Chiba H., Sawada N., Yokozaki H. Hypermethylation-modulated downregulation of claudin-7 expression promotes the progression of colorectal carcinoma. Pathobiology 2008, 75:177-185.
121. Oshima T., Kunisaki C., Yoshihara K., Yamada R., Yamamoto N., Sato T., Makino H., Yamagishi S., Nagano Y., Fujii S., Shiozawa M., Akaike M., Wada N., Rino Y., Masuda M., Tanaka K., Imada T. Reduced expression of the claudin-7 gene correlates with venous invasion and liver metastasis in colorectal cancer. Oncol. Rep. 2008, 19:953-959.
122. Kinugasa T., Huo Q., Higashi D., Shibaguchi H., Kuroki M., Tanaka T., Futami K., Yamashita Y., Hachimine K., Maekawa S., Nabeshima K., Iwasaki H. Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res. 2007, 27:3729-3734.
123. Huo Q., Kinugasa T., Wang L., Huang J., Zhao J., Shibaguchi H., Kuroki M., Tanaka T., Yamashita Y., Nabeshima K., Iwasaki H. Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer. Anticancer Res. 2009, 29:851-857.
124. Grone J., Weber B., Staub E., Heinze M., Klaman I., Pilarsky C., Hermann K., Castanos-Velez E., Ropcke S., Mann B., Rosenthal A., Buhr H.J. Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12. Int. J. Colorectal Dis. 2007, 22:651-659.
125. Konecny G.E., Agarwal R., Keeney G.A., Winterhoff B., Jones M.B., Mariani A., Riehle D., Neuper C., Dowdy S.C., Wang H.J., Morin P.J., Podratz K.C. Claudin-3 and claudin-4 expression in serous papillary, clear-cell, and endometrioid endometrial cancer. Gynecol. Oncol. 2008, 109:263-269.
126. Szabo I., Kiss A., Schaff Z., Sobel G. Claudins as diagnostic and prognostic markers in gynecological cancer. Histol. Histopathol. 2009, 24:1607-1615.
127. Pan X.Y., Wang B., Che Y.C., Weng Z.P., Dai H.Y., Peng W. Expression of claudin-3 and claudin-4 in normal, hyperplastic, and malignant endometrial tissue. Int. J. Gynecol. Cancer 2007, 17:233-241.
128. Miyamoto K., Kusumi T., Sato F., Kawasaki H., Shibata S., Ohashi M., Hakamada K., Sasaki M., Kijima H. Decreased expression of claudin-1 is correlated with recurrence status in esophageal squamous cell carcinoma. Biomed Res. 2008, 29:71-76.
129. Tsunoda S., Smith E., De Young N.J., Wang X., Tian Z.Q., Liu J.F., Jamieson G.G., Drew P.A. Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma. Oncol. Rep. 2009, 21:1067-1073.
130. Usami Y., Chiba H., Nakayama F., Ueda J., Matsuda Y., Sawada N., Komori T., Ito A., Yokozaki H. Reduced expression of claudin-7 correlates with invasion and metastasis in squamous cell carcinoma of the esophagus. Hum. Pathol. 2006, 37:569-577.
131. Lioni M., Brafford P., Andl C., Rustgi A., El-Deiry W., Herlyn M., Smalley K.S. Dysregulation of claudin-7 leads to loss of E-cadherin expression and the increased invasion of esophageal squamous cell carcinoma cells. Am. J. Pathol. 2007, 170:709-721.
132. Satake S., Semba S., Matsuda Y., Usami Y., Chiba H., Sawada N., Kasuga M., Yokozaki H. Cdx2 transcription factor regulates claudin-3 and claudin-4 expression during intestinal differentiation of gastric carcinoma. Pathol. Int. 2008, 58:156-163.
133. Xin S., Huixin C., Benchang S., Aiping B., Jinhui W., Xiaoyan L., Yu W.B., Minhu C. Expression of Cdx2 and claudin-2 in the multistage tissue of gastric carcinogenesis. Oncology 2007, 73:357-365.
134. Song X., Li X., Tang Y., Chen H., Wong B., Wang J., Chen M. Expression of claudin-2 in the multistage process of gastric carcinogenesis. Histol. Histopathol. 2008, 23:673-682.
135. Ohtani S., Terashima M., Satoh J., Soeta N., Saze Z., Kashimura S., Ohsuka F., Hoshino Y., Kogure M., Gotoh M. Expression of tight-junction-associated proteins in human gastric cancer: downregulation of claudin-4 correlates with tumor aggressiveness and survival. Gastric Cancer 2009, 12:43-51.
136. Agarwal R., Mori Y., Cheng Y., Jin Z., Olaru A.V., Hamilton J.P., David S., Selaru F.M., Yang J., Abraham J.M., Montgomery E., Morin P.J., Meltzer S.J. Silencing of claudin-11 is associated with increased invasiveness of gastric cancer cells. PLoS One 2009, 4:e8002.
137. Yano K., Imaeda T., Niimi T. Transcriptional activation of the human claudin-18 gene promoter through two AP-1 motifs in PMA-stimulated MKN45 gastric cancer cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294:G336-G343.
138. Higashi Y., Suzuki S., Sakaguchi T., Nakamura T., Baba S., Reinecker H.C., Nakamura S., Konno H. Loss of claudin-1 expression correlates with malignancy of hepatocellular carcinoma. J. Surg. Res. 2007, 139:68-76.
139. Lee J.W., Hsiao W.T., Chen H.Y., Hsu L.P., Chen P.R., Lin M.D., Chiu S.J., Shih W.L., Hsu Y.C. Upregulated claudin-1 expression confers resistance to cell death of nasopharyngeal carcinoma cells. Int. J. Cancer 2010, 126:1353-1366.
140. Dos Reis P.P., Bharadwaj R.R., Machado J., Macmillan C., Pintilie M., Sukhai M.A., Perez-Ordonez B., Gullane P., Irish J., Kamel-Reid S. Claudin 1 overexpression increases invasion and is associated with aggressive histological features in oral squamous cell carcinoma. Cancer 2008, 113:3169-3180.
141. Oku N., Sasabe E., Ueta E., Yamamoto T., Osaki T. Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res. 2006, 66:5251-5257.
142. Kleinberg L., Holth A., Trope C.G., Reich R., Davidson B. Claudin upregulation in ovarian carcinoma effusions is associated with poor survival. Hum. Pathol. 2008, 39:747-757.
143. Morin P.J. Claudin proteins in ovarian cancer. Dis. Markers 2007, 23:453-457.
144. Karanjawala Z.E., Illei P.B., Ashfaq R., Infante J.R., Murphy K., Pandey A., Schulick R., Winter J., Sharma R., Maitra A., Goggins M., Hruban R.H. New markers of pancreatic cancer identified through differential gene expression analyses: claudin 18 and annexin A8. Am. J. Surg. Pathol. 2008, 32:188-196.
145. Landers K.A., Samaratunga H., Teng L., Buck M., Burger M.J., Scells B., Lavin M.F., Gardiner R.A. Identification of claudin-4 as a marker highly overexpressed in both primary and metastatic prostate cancer. Br. J. Cancer 2008, 99:491-501.
146. Lechpammer M., Resnick M.B., Sabo E., Yakirevich E., Greaves W.O., Sciandra K.T., Tavares R., Noble L.C., DeLellis R.A., Wang L.J. The diagnostic and prognostic utility of claudin expression in renal cell neoplasms. Mod. Pathol. 2008, 21:1320-1329.
147. Li L., Yao J.L., di Sant'Agnese P.A., Bourne P.A., Picken M.M., Young A.N., Shen S.S., Huang J. Expression of claudin-7 in benign kidney and kidney tumors. Int. J. Clin. Exp. Pathol. 2008, 1:57-64.
148. Hornsby C.D., Cohen C., Amin M.B., Picken M.M., Lawson D., Yin-Goen Q., Young A.N. Claudin-7 immunohistochemistry in renal tumors: a candidate marker for chromophobe renal cell carcinoma identified by gene expression profiling. Arch. Pathol. Lab. Med. 2007, 131:1541-1546.
149. Choi Y.D., Kim K.S., Ryu S., Park Y., Cho N.H., Rha S.H., Jang J.J., Ro J.Y., Juhng S.W., Choi C. Claudin-7 is highly expressed in chromophobe renal cell carcinoma and renal oncocytoma. J. Korean Med. Sci. 2007, 22:305-310.
150. Tzelepi V.N., Tsamandas A.C., Vlotinou H.D., Vagianos C.E., Scopa C.D. Tight junctions in thyroid carcinogenesis: diverse expression of claudin-1, claudin-4, claudin-7 and occludin in thyroid neoplasms. Mod. Pathol. 2008, 21:22-30.
151. Bello I.O., Vilen S.T., Niinimaa A., Kantola S., Soini Y., Salo T. Expression of claudins 1, 4, 5, and 7 and occludin, and relationship with prognosis in squamous cell carcinoma of the tongue. Hum. Pathol. 2008, 39:1212-1220.